{
    "id": 27369,
    "fullName": "EDNRB positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "EDNRB positive indicates the presence of the EDNRB gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 1910,
        "geneSymbol": "EDNRB",
        "terms": [
            "EDNRB",
            "ABCDS",
            "ET-B",
            "ET-BR",
            "ETB",
            "ETB1",
            "ETBR",
            "ETRB",
            "HSCR",
            "HSCR2",
            "WS4A"
        ]
    },
    "variant": "positive",
    "createDate": "01/04/2018",
    "updateDate": "01/04/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 12656,
            "approvalStatus": "Phase I",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase I trial, lesions from melanoma patients treated with BQ788 demonstrated decreased expression of EDNRB, reduced cell proliferation, and in one patient treated for more than one week, inhibition of lesion growth (PMID: 26330458; NCT02442466).",
            "molecularProfile": {
                "id": 28810,
                "profileName": "EDNRB positive"
            },
            "therapy": {
                "id": 6551,
                "therapyName": "BQ788",
                "synonyms": null
            },
            "indication": {
                "id": 1909,
                "name": "melanoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 10543,
                    "pubMedId": 26330458,
                    "title": "First-in-Human Proof-of-Concept Study: Intralesional Administration of BQ788, an Endothelin Receptor B Antagonist, to Melanoma Skin Metastases.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26330458"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 28810,
            "profileName": "EDNRB positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}